4-苯甲基-2-甲基-1,2,4-噻二唑烷-3,5-二酮
- CAS编号: 327036-89-5
- 分子式: C10H10N2O2S
- 分子量: 222.26
- MDL号: MFCD04973552
- PubChem编号: 4124851
库存信息
库存信息
库存信息
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
T126722-5mg | 5mg | 现货 | | |
T126722-25mg | 25mg | 现货 | | |
T126722-100mg | 100mg | 现货 | |
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
T126722-5mg | 5mg | 现货 | | |
T126722-25mg | 25mg | 现货 | | |
T126722-100mg | 100mg | 现货 | |
规格或纯度 | ≥98% |
---|---|
英文名称 | TDZD-8 |
别名 | TDZD 8;TDZD8;NP 01139 |
英文别名 | TDZD 8;TDZD8;GSK-3β Inhibitor I;NP 01139;4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione |
生化机理 | TDZD-8 is a selective inhibitor of GSK-3, a thiadiazolidinone derivative, non-ATP competitive inhibitor of GSK-3β (IC50 = 2 μM). It does not inhibit Cdk-1/cyclin B, CK-II, PKA or PKC at >100 μM. TDZD-8 has been proposed to bind to the kinase site of GSK-3β.Selective, non-ATP competitive GSK-3β inhibitor (IC 50 = 2 μM). Binds to the active site of GSK3β. Also inhibits PKC activity (IC 50 values are 1.4, 1.1 and 5.5 μM at βI, δ and ι isoforms respectively). |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
TDZD-8(NP 01139)是thiadiazolidinone的衍生物,是非ATP竞争性GSK-3β抑制剂,IC50为2 μM,对Cdk-1/cyclin B,CK-II,PKA和PKC无活性。TDZD-8 has been used to study the role of GSK-3 in maintaining MLL leukemia stem cell transcriptional program;TDZD-8 has also been used to analyze its effect on neural functions of the mouse olfactory bulb. TDZD-8(NP 01139) is a selective inhibitor of GSK-3, a thiadiazolidinone derivative, non-ATP competitive inhibitor of GSK-3β (IC50 = 2 μM); does not inhibit Cdk-1/cyclin B, CK-II, PKA or PKC at >100 μM. |
IUPAC Name | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione |
---|---|
INCHI | InChI=1S/C10H10N2O2S/c1-11-9(13)12(10(14)15-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3 |
InChi Key | JDSJDASOXWCHPN-UHFFFAOYSA-N |
Canonical SMILES | CN1C(=O)N(C(=O)S1)CC2=CC=CC=C2 |
分子式 |
C10H10N2O2S |
PubChem CID | 4124851 |
分子量 | 222.26 |
PubChem CID | 4124851 |
---|---|
ChEMBL Ligand | CHEMBL284861 |
CAS Registry No. | 327036-89-5 |
Reactome Reaction | R-HSA-9687724 |
Reactome Drug | R-ALL-9687653 |
RCSB PDB Ligand | U3W |
溶解性 | 25°C: DMSO |
---|---|
敏感性 | 对光敏感、对空气敏感、对热敏感 |
熔点 | 63 °C |
象形图 |
Health Hazard |
---|---|
信号词 | Danger |
危险声明 |
H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled |
预防措施声明 | P261,P501,P284,P304+P340,P342+P316 |
WGK Germany | 3 |
个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Target ID | 2030 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
名称 | glycogen synthase kinase 3 beta | ||||||||||||||||||||||||
缩写名 | GSK3B | ||||||||||||||||||||||||
家族 | GSK subfamily | ||||||||||||||||||||||||
基因和蛋白信息 |
|
||||||||||||||||||||||||
Ensembl Gene | ENSG00000082701 (Hs) , ENSMUSG00000022812 (Mm) , ENSRNOG00000002833 (Rn) | ||||||||||||||||||||||||
Entrez Gene | 2932 (Hs) , 56637 (Mm) , 84027 (Rn) | ||||||||||||||||||||||||
OMIM | 605004 (Hs) | ||||||||||||||||||||||||
UniProtKB | P18266 (Rn) , P49841 (Hs) , Q9WV60 (Mm) | ||||||||||||||||||||||||
RefSeq Nucleotide | NM_001146156 (Hs) , NM_019827 (Mm) , NM_032080 (Rn) | ||||||||||||||||||||||||
RefSeq Protein | NP_001139628 (Hs) , NP_062801 (Mm) , NP_114469 (Rn) | ||||||||||||||||||||||||
Protein GI | 225903437 (Hs) , 9790077 (Mm) , 14091770 (Rn) | ||||||||||||||||||||||||
ChEMBL Target | CHEMBL3669 (Rn) , CHEMBL1075321 (Mm) , CHEMBL262 (Hs) |
Ligand ID | 5977 |
---|---|
名称 | GSK-3beta inhibitor I |
别名 | TDZD-8 |
类别 | Synthetic organic |
学名 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione |
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
评价 |
Using the code TDZD-8, this compound is used as a reference compound in |
1. Martinez A, Alonso M, Castro A, Pérez C, Moreno FJ. (2002) First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.. J Med Chem, 45 (6): (1292-9). [PMID:11881998] |
2. Kaidanovich-Beilin O, Eldar-Finkelman H. (2006) Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.. J Pharmacol Exp Ther, 316 (1): (17-24). [PMID:16169938] |
3. Zhang P, Hu HR, Huang ZH, Lei JY, Chu Y, Ye DY. (2012) Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.. Bioorg Med Chem Lett, 22 (23): (7232-6). [PMID:23099099] |